Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v4-FR
Language French French
Date Updated 2022-02-04 2022-01-14
Drug Identification Number 02239699 02239699
Brand name APO-DIVALPROEX APO-DIVALPROEX
Common or Proper name DIVALPROEX DIVALPROEX
Company Name APOTEX INC APOTEX INC
Ingredients VALPROIC ACID VALPROIC ACID
Strength(s) 250MG 250MG
Dosage form(s) TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code N03AG N03AG
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-03 2022-01-03
Estimated end date 2022-02-04 2022-01-28
Actual end date 2022-02-01
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments There was a partial release in the week of January 24; full release by February 4
Health Canada comments